Alpha-Ketoglutaric Acid

Alpha-Ketoglutaric Acid

SCHEMBL1469855

NCCCC(=O)O.O=C(O)CCC(=O)C(=O)O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.71
TSHR P16473 3/20 0.71
THRB P10828 2/20 0.71
BLM P54132 2/20 0.71
KMT2A Q03164 2/20 0.71
NPSR1 Q6W5P4 2/20 0.71
GABRR1 P24046 2/20 0.71
GABRR3 A8MPY1 1/20 0.71
GABRP O00591 1/20 0.71
GABRD O14764 1/20 0.71
HDAC3 O15379 1/20 0.71
GABBR2 O75899 1/20 0.71
CYP1A2 P05177 1/20 0.71
GABRA1 P14867 1/20 0.71
GABRB1 P18505 1/20 0.71
GABRG2 P18507 1/20 0.71
GABRB3 P28472 1/20 0.71
GABRR2 P28476 1/20 0.71
SLC6A1 P30531 1/20 0.71
GABRA5 P31644 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alpha-Ketoglutaric Acid SCHEMBL16412456 1.00 LMNA (0.71) LMNATSHRTHRBBLMKMT2A
Alpha-Ketoglutaric Acid SCHEMBL1469844 0.93 NFKB1 (0.73) LMNATSHRTHRBBLMKMT2A
Alpha-Ketoglutaric Acid SCHEMBL20817532 0.93 EGLN1 (0.70) LMNATSHRTHRBBLMKMT2A
Alpha-Ketoglutaric Acid SCHEMBL1261453 0.85 EGLN1 (0.74) LMNATSHRTHRBBLMKMT2A
Gamma-Aminobutyric Acid SCHEMBL31280548 0.85 LMNA (0.88) LMNATSHRTHRBBLMKMT2A
SCHEMBL728986 0.85
Alpha-Ketoglutaric Acid SCHEMBL9121 0.85 EGLN1 (0.82) LMNATSHRTHRBBLMKMT2A
Gamma-Aminobutyric Acid SCHEMBL4878 0.84
Gamma-Aminobutyric Acid SCHEMBL3973563 0.84 LMNA (1.00) LMNATSHRTHRBBLMKMT2A
Gamma-Aminobutyric Acid SCHEMBL190459 0.84 LMNA (1.00) LMNATSHRTHRBBLMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117083388-A Recombinant polypeptides having acyl-CoA compound reducing activity 旭化成株式会社 2023-11-17 CN claimed
US-20240052297-A1 MESOPHILIC, METHYLOTROPHIC BACTERIA FOR THE PH-INDEPENDENT PRODUCTION OF BIOCHEMICALS ACIES BIO D.O.O. (SI) 2024-02-15 US disclosed
CN-117500912-A Recombinant microorganism having diamine-producing ability and process for producing diamine 旭化成株式会社 2024-02-02 CN disclosed
CN-117441008-A Recombinant microorganism and method for producing C6 compound 旭化成株式会社 2024-01-23 CN disclosed
CN-117083388-A Recombinant polypeptides having acyl-CoA compound reducing activity 旭化成株式会社 2023-11-17 CN disclosed
CN-109072261-B Process for producing L-glufosinate 巴斯夫欧洲公司 2023-03-17 CN disclosed
CN-113197207-B Flavoring agent and method for improving flavor of pumpkin leaf taro 广东省农业科学院蔬菜研究所 2021-12-17 CN disclosed
CN-113197207-A Flavoring agent and method for improving flavor of pumpkin leaf taro 广东省农业科学院蔬菜研究所 2021-08-03 CN disclosed
CN-112739822-A Method for improving L-glufosinate-ammonium yield 巴斯夫欧洲公司 2021-04-30 CN disclosed
US-20190091300-A1 METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2019-03-28 US disclosed
WO-2015092599-A1 IMPROVED PROCESS FOR THE PRODUCTION OF GAMMA-AMINOBUTYRIC ACID (GABA) BASF SE (DE) 2015-06-25 WO disclosed
US-9034319-B2 Methods of treating cancer of the central nervous system YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2015-05-19 US disclosed
US-20110070218-A1 METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2011-03-24 US disclosed
US-7767204-B2 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2010-08-03 US disclosed
US-20090304661-A1 Method And Composition For Proctecting Neuronal Tissue From Damage Induced By Elevated Glutamate Levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. AT THE WEIZMANN INSTITUTE OF SCEINCE (IL) 2009-12-10 US disclosed
US-20090186358-A1 Pathway Analysis of Cell Culture Phenotypes and Uses Thereof WYETH (US) 2009-07-23 US disclosed
US-20080233099-A1 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2008-09-25 US disclosed
US-20080233096-A1 transaminase, dehydrogenase, decarboxylase, ligase as glutamate modifying enzymes and oxaloacetate, pyruvate, NAD+, NADP+, 2-oxohexanedioic acid, 2-oxo-3-sulfopropionate, 2-oxo-3-sulfinopropionic acid, 2-oxo-3-phenylpropionic acid co-factors to enhance brain to blood efflux YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2008-09-25 US disclosed
US-7404951-B2 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2008-07-29 US disclosed
US-20060024284-A1 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2006-02-02 US disclosed